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OVERVIEW 
 
 
 
 Aims M&M Results Conclusions 
Study 
I 
Evaluate a 
collagen-PCL 
scaffold with 
minced bladder 
mucosa in vitro 
Minced tissue was 
cultured on top of the 
scaffold. Scaffold 
properties were 
evaluated. 
Good proliferation. 
Multilayered 
epithelium after 4 
weeks. High tensile 
strength. 
Transplant with 
favorable properties for 
reconstruction of 
urogenital tract in one 
single-staged surgery. 
Study 
II 
Evaluate a 
collage-PLGA 
scaffold with 
minced bladder 
mucosa in vitro 
Minced tissue was 
cultured on top and 
inside the scaffold. 
Scaffold properties 
were evaluated. 
Good proliferation. 
Multilayered 
epithelium after 4 
weeks. High tensile 
strength. 
Transplant with 
favorable properties for 
reconstruction of 
urogenital tract in one 
single-staged surgery. 
Study 
III 
Evaluate 
differentiation of 
bone marrow 
MSCs into 
urothelium, 
separately or on 
top of a collagen-
PCL scaffold 
MSCs were co-
cultured with 
urothelium or 
cultured with 
conditioned medium. 
MSCs were also 
differentiated on the 
scaffold. 
MSCs differentiated 
into urothelial-like 
cells after 14 days 
with both methods, 
and on top of the 
collagen-PCL 
scaffold. 
In the future, autologous 
bone marrow MSCs 
may be a source for 
urogenital regenerative 
medicine in cases with 
lack of native urothelial 
cells. 
Study 
IV 
Evaluate a 
collagen-PCL 
scaffold with 
minced skin in a 
rat model. 
Minced skin was 
cultured on top of a 
collagen-PCL 
scaffold in vitro and 
in vivo, in a 
subcutaneous rat 
model. Scaffold 
properties were 
evaluated. 
Good integration of 
scaffold. 
Keratinocyte 
proliferation on top 
of the scaffold that 
kept its tensile 
strength and 
elasticity. 
Cell expansion on top of 
the scaffold could take 
place after 
transplantation in vivo. 
This may facilitate 
future urogenital 
reconstruction and 
autologous tissue 
expansion without in 
vitro cell culturing. 
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1 BACKGROUND 
1.1 GENERAL 
As a young surgeon, the most challenging situations I have encountered are when tissue is 
lacking. Treatment options when there is a lack of tissue due to different diseases and 
diagnosis are available in today’s medicine. However, after for example severe trauma, 
surgical treatment of cancer, and congenital malformations there are sometimes limitations to 
our treatment options and the feasibility of treatment can be limited due to tissue shortage. 
Tissue engineering may lead to new solutions for these patients and give rise to better 
therapies and results. 
Focus has been on the lower urinary tract particularly for children with congenital 
malformations. The urinary system consists of several organs in order to produce urine, 
transport the urine through the ureters to the bladder and store it in the bladder before 
elimination out of the body by the urethra. The function of the urinary organs is to maintain 
the body homoeostasis by regulating the water and ionic balance and at the same time 
achieve an active life with controlled continence (Rasouly and Lu 2013). We seek to find 
ways to engineer the bladder and urethra to restore the function of storing and eliminating 
urine in a controlled manner when there is a need of intervention.  
1.2 EMBRYOLOGY OF THE URINARY TRACT 
The cloaca is formed from the hindgut of the embryo, and is present up until week 7 of 
gestation. During week 7, the cloaca is divided by the urorectal septum into a ventral part, the 
urogenital sinus, and a dorsal part, which develops to form the anorectal canal. The urogenital 
sinus is usually divided into the cranial part or the vesical part, which will form the future 
bladder and the caudal part developing into the rest of the lower urogenital tract, such as the 
future urethra, prostate and external genitalia. The vesical part is connected to the allantois 
and functions in early fetal life as an outflow tract to drain the early developing bladder 
connected to the umbilical cord. The allantois regresses by week 15 of gestation and the 
bladder then separates from the umbilical cord. The remnant of the allantois, the urachus, is 
further elongated to form the median umbilical ligament. The posterior part of the 
vesicourethral canal develops into the pelvic parts of the urethra in the male and the full 
urethra in the female.  
After 4-5 weeks of gestation the common nephric duct integrates into the lower part of the 
urogenital sinus where the future bladder neck will be situated. After the fusion, the orifice 
moves anteriorly and separates the common nephric ducts from the Wolffian duct. Further 
development of the bladder repositions the ureteric orifices, and with the internal urethral 
orifice they form a triangular area, which is their final position in the bladder wall called the 
trigone. Traditionally the trigone has been considered the only part of the bladder that is 
structurally different from the rest of the lower urinary tract, and recent studies have shown 
that it is most likely also derived from an endodermal layer. 
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In the early days of the bladder when it is still part of the urogenital sinus, it consists of 
bilayered cuboidal cells surrounded by undifferentiated mesenchymal cells. At about 12 
weeks of gestation the mesenchymal bladder cells start differentiating into smooth muscle 
cells and by week 21 the bladder cells are similar to the full-grown bladder with 3-5 layers of 
urothelial cells and 3 layers of longitudinal and circular smooth muscle.  
Bladder compliance is important for the function of the bladder, which is to store and empty 
urine at a desired time, although the formation and development of bladder compliance is 
mostly unknown. 
The sphincters give rise to the continence function of the bladder and are developed in a 
similar manner in both females and males. The formation of the sphincters arises from a 
combination of the trigone, bladder detrusor and urethral sphincter complex. When the 
detrusor matures, it also forms a muscle band around the ureteric orifices and functions as the 
ureterovesical sphincters, which closes the orifices when the bladder contracts during 
voiding. This ostial-valve functions as an anti-reflux mechanism preventing the flow of urine 
back to the kidneys. 
(Newman and Antonakopoulos 1989, Shafik 1996, Vize, Woolf et al. 2003, Yucel and 
Baskin 2004, Thomas, DeMarco et al. 2005, Viana, Batourina et al. 2007, Tanaka, Ishii et al. 
2010, Rasouly and Lu 2013, Wein, Kavoussi et al. 2016)  
 
 
 
 
 
 
1.3 BLADDER ANATOMY 
The bladder of an adult human is located extra peritoneal in the anterior part of the pelvis and 
is surrounded by connective tissue and fat. The proximal part of the bladder is covered by 
peritoneum all the way to the bladder neck. The true ligaments of the pelvis and parts of the 
pelvic fascia attaches and fixates the bladder neck. In females the body of the bladder gets 
inferior support from the pelvic diaphragm and from the prostate in males. From the lateral 
sides the bladder gets its support from the levator ani muscles and the obturator internus. The 
trigone is an important anatomical part of the bladder floor consisting of the urethral opening 
and the two urethral orifices creating a triangular area. (Fowler 2008, Kingsnorth 2000) 
Figure 1: Development of the urogenital tract. Picture from www.slideshare.net, modified by 
the author. 
 
Week 5 Week 7 Week 8 
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1.4 BLADDER HISTOLOGY 
The most organized part of the bladder is at the bladder neck consisting of three different 
layers, the inner longitudinal muscular layer, the middle circumferential or circular muscular 
layer and the external longitudinal muscular layer. The bladder neck is also used as the inner 
sphincter. The detrusor is arranged in the same manner but the layers are more distinct at the 
neck. In the trigone, there are two muscular layers, the superficial layer, which connects to 
the longitudinal urethral muscles and the deep muscle layer which connects to the detrusor.  
Towards the luminal side of the bladder from the detrusor there is a connective tissue layer 
called the lamina propria, which connects the detrusor to the bladder mucosa consisting of 
urothelium. The lamina propria has vast microvasculature to support the epithelium. The 
bladder mucosa, the urothelium, is a transitional epithelium that consists of flat and cuboidal 
cells with the capacity to stretch and constrict so the bladder can function properly. The outer 
part of the cell lining consists of umbrella cells. These cells form an impermeable surface and 
an osmotic barrier to make sure the urine is not reabsorbed by the body. A layer of 
glycosaminoglycans covers the luminal surface of the umbrella cells, giving the cells a layer 
of protection from harmful substances and helping in the barrier function.  
(Kingsnorth, Skandalakis et al. 2000, Woo, Hijaz et al. 2007, Fowler, Griffiths et al. 2008, 
Phull, Pan et al. 2011, Walters and Karram 2015) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Anatomy of the female bladder (left), picture from www.slideshare.net and 
modified by the author. Histology of the urinary bladder (right), from Wikipedia, Urinary 
Bladder, CC BY-SA 3.0, modified by the author. 
Transitional 
epithelium Lamina propria 
Submucosa 
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1.5 SKIN HISTOLOGY 
The skin consists of two parts, the epidermis and dermis, and below there is a subcutaneous 
layer which consists of fatty tissue and larger blood vessels.  
The epidermis consists of keratinized stratified squamous epithelium made up of four types of 
cells, keratinocytes, melanocytes, Langerhans cells and Merkel cells. Keratinocytes constitute 
over 90% of the epidermis and establish several layers as they ascend upwards to the surface. 
In the basal layer the keratinocytes are columnar cells separating dermis from epidermis. The 
next layer is the stratum spinosum where the keratinocytes develop desmosomes and attach to 
adjacent cells. In the third layer, stratum granulosum, the keratinocytes become squamous 
cells containing keratohyaline, which is a precursor to keratin. The last and most superficial 
layer, stratum corneum, is the most important layer and functions as a water repellant barrier. 
It consists of several layers of flattened cells without a nucleus, and contains the final keratin, 
which is a combination of keratohyaline and cytokeratin.  
The dermis is separated from the epidermis by the basement membrane and consists of two 
layers, the papillary layer and the reticular layer. The most superficial layer of the dermis is 
the papillary layer and contains most of the nerves, sensory receptors and blood vessels. The 
reticular layer consists of dense collagenous connective tissue. The dermis provides the skin 
with its tensile strength and elasticity. 
(Urmacher 1990, Kanitakis 2002) 
 
 
Figure 3: Basic skin histology. Picture from https://www.slideshare.net/moha_az/basic-skin-
histology. 
  11 
1.6 TISSUE ENGINEERING 
The term tissue engineering which is also referred to as regenerative medicine, was first 
mentioned in 1985 when bioengineering pioneer Y.C. Fung of the University of California 
submitted a proposal to the National Science Foundation in the US for an Engineering 
Research Center Program award under the title “Center for the Engineering of Living 
Tissues”. The first formal scientific meeting with the term tissue engineering was held in 
1987 (Schultheiss, Bloom et al. 2000). 
Tissue engineering is the merging of the clinical and scientific fields with engineering. Since 
the start of tissue engineering, the number of researchers and research papers within the field 
has grown exponentially. This has given rise to multidisciplinary cooperation across different 
fields and is today almost a requirement for successful research within the field of tissue 
engineering. Theoretical advantages when using autologous cells for tissue regeneration are: 
no foreign body reaction, grows with the patient, re-models according to local 
microenvironment and could potentially give rise to an unlimited number of cells. 
The common way of tissue engineering with autologous cells is usually performed via several 
steps. In the first step, cells are harvested in different ways from the chosen organ or 
alternatively stem cells are harvested. The next step is to grow and cultivate the cells to the 
required amount and if there are stem cells they may need to be induced and differentiated 
into the intended cells. A scaffold resembling the organ of interest is produced and the cells 
are cultured within or on top of the scaffold. After the preparation of the scaffold is finished, 
a second surgical procedure is conducted and the transplant is put in place to expand or repair 
the intended organ (Chester, Balderson et al. 2004, Fossum, Svensson et al. 2007, Bowland, 
Ingham et al. 2015).  
Today, tissue engineering of most organs is feasible and/or under clinical trials. For example, 
the skin, cartilage, vessels, bladder and urethra are some of the organs that have been 
investigated in human trials. The most common clinical tissue engineering application is 
currently performed in patients with burn injuries. Cultured sheets of human autologous 
keratinocytes have been used as a skin substitute in clinics for severe burn injuries, but this 
technique is still not widely used mostly because of the associated costs (Horch, Kopp et al. 
2005). 
There are problems facing the standard procedure of tissue engineering, including a long time 
for culturing (up to 7-8 weeks), the associated high cost, the requirement of advanced and 
highly specialized personnel and laboratories to conduct the process and the patient in 
addition must undergo two surgical procedures, for harvesting and later transplantation. To 
circumvent these problems, another idea behind tissue expansion is to guide the body to 
expand and regenerate tissue after a designed pattern using the body as an incubator. This 
would only require one surgical procedure and would bypass the downsides of traditional 
tissue engineering. This would, however, also require a higher standard during the initial 
operation and place especially high demands on the scaffold. 
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Meek introduced a theory in 1958 where he described how skin epithelium would regenerate 
from the edge of a cut surface of the skin by cell division and migration (Figure 4) (Meek 
1958). This led to the idea that by cutting a piece of skin into two pieces, it would produce a 
longer boarder from where the cells can migrate and regenerate. Surgically minced tissue into 
sub millimeter parts has been shown to be able to repair a wound and give a 100-fold 
expansion of a skin graft (Hackl, Bergmann et al. 2012). In our group, we have also shown 
that it is possible to expand minced bladder mucosa to form a conduit to the bladder by a 3-
fold expansion of the tissue (Reinfeldt Engberg, Lundberg et al. 2013). For these methods to 
be applicable on the bladder and/ or urethra a suitable scaffold would be needed with high 
tensile strength, that can be handled surgically, is biodegradable, and leads to a good 
proliferation of cells.  
 
 
Figure 4: The theory of Meek. By cutting a piece of tissue into two pieces the total 
circumference increases and leads to a longer border from which cells can proliferate.  
The scaffold may be the most important part of the steps in tissue engineering an organ and 
the success rate may depend on it. In bladder augmentation studies where a seeded PLGA 
copolymer scaffold was used, initial results showed a moderate benefit but a later phase-II 
trial had to be discontinued due to adverse effects, which included severe complications such 
as bladder perforation and bowel obstruction. Another smaller study using small intestinal 
submucosa showed better results, but without a clear clinical benefit. These results could be 
due to the scaffold properties or the lack of integration of the scaffold. In other organs, 
clinical implementations have also shown adverse effects, which could be related to the 
scaffold properties. Regeneration of skin with autologous sheets has shown poor results in 
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respect to mechanical stress. Clinical use of tissue engineered cartilage as well as arteries 
have also been associated with several scaffold-associated hurdles, such as lack of high 
tensile strength, lack of integration into the surrounding tissue, and lack of elasticity and 
compliance over time (Horch, Kopp et al. 2005, McBane, Sharifpoor et al. 2012, Joseph, 
Borer et al. 2014, Sloff, Simaioforidis et al. 2014, Bauge and Boumediene 2015, Bowland, 
Ingham et al. 2015).  
When constructing a scaffold for the bladder there is a need for high tensile strength and 
elasticity, and the surgeon must also be able to handle the scaffold with ease. At the same 
time the scaffold should provide a beneficial environment for the cells to proliferate and 
migrate. Collagens are proteins that are part of the extracellular matrix in all species and 
provide good cell proliferation properties. The draw-back is that collagen has little 
mechanical strength and cannot be handled surgically. By low mechanical pressure it is 
possible to extract water from the collagen and thus reduce the volume more than 100 times. 
The phenomenon is called “plastic compression”, and gives the collagen higher tensile 
strength. Despite the enhancement, the strength is unfortunately still too low for bladder 
augmentation purposes. (Brown, Wiseman et al. 2005, Martins, Filho et al. 2011) We have 
therefore investigated different polymers inside of our scaffold for additional strength and 
support. The first polymer was knitted Poly(ɛ-caprolactone) (PCL) which gives a higher 
compliance and degrades more slowly. The second polymer was electrospun poly(lactic-co-
glycolide) (PLGA) which resembles the extracellular matrix and degrades at a faster rate. 
Both polymers are synthetic and biodegradable (Brown, Wiseman et al. 2005, Li, 
Mondrinos et al. 2006, Engelhardt, Stegberg et al. 2010, Woodruff and Hutmacher 2010). 
Another issue that may arise when reconstructing an organ, or part of an organ, is the lack of 
cells. In traditional tissue engineering, the cells being used are from the targeted organ. In 
some cases, such as after severe trauma or after malignancy, cell harvesting may not be 
possible due to lack of cells or because of the risk of developing new malignancies. In these 
circumstances stem cells could be a possible solution. Mesenchymal stem cells harvested 
from the bone marrow are multipotent cells and can be induced into several lineages, such as 
osteoblasts, chondrocytes and adipocytes. They are easy to isolate and expand in culture. 
Mesenchymal stem cell transplantations have been in clinical use for over 15 years and 
several hundred patients have been treated without negative effects. For these reasons, we 
decided to also study these cells for bladder augmentation purposes (Petersen, Bowen et al. 
1999, Pittenger, Mackay et al. 1999, Koc, Gerson et al. 2000, Sanchez-Ramos, Song et al. 
2000, Le Blanc, Rasmusson et al. 2004, Oswald, Boxberger et al. 2004, Bernardo, Zaffaroni 
et al. 2007, Prockop, Brenner et al. 2010, von Bahr, Batsis et al. 2012). 
1.7 BLADDER EXSTROPHY 
Bladder exstrophy is part of the extrophy-epispadias complex and is a severe form of an 
abdominal midline malformation. Structures involved in the malformation include the 
abdominal wall, the urinary system, the genitalia, the pelvis, the pelvic floor and could also 
involve the spine and the anus, as in cloacal malformation, the most severe form.  
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The prevalence of the malformation varies in the published data and ranges from 2-4 per 
100 000 live births. The male to female ratio has been reported as 1.14-6:1 and caucasian 
infants seem to have a higher prevalence overall.  
The new-born child with bladder exstrophy presents with an open bladder of varying size in 
the lower midline of the abdomen. The ureteric orifices are visible and dripping urine. The 
bladder mucosa is affected and mucosal polyps may be present. If closure has been delayed 
further signs of inflammation may be present. Rectus diastasis is always present and bilateral 
inguinal hernias are present in most patients. 
The genitalia of the patients are affected differently depending on the gender. In the new-born 
male, the urethral plate is open (epispadic) and covers all the dorsal portion of the penis, 
which puts both corpora cavernosa below the urethral plate. The penis is dorsally curved and 
is shorter than normal. In the female child, the clitoris is split around an open urethral plate, 
the perineum is shortened and the vagina is narrower than normal. There is also a wide pubic 
diastasis and a rotational displacement of the pelvis in both gender. 
There are different ways to manage the malformation. The golden standard is functional 
reconstruction. Earlier, a much simpler method was to remove the bladder and perform a 
urinary diversion and, later, a sigmoid pouch. Functional bladder reconstruction can today be 
performed in one, two or three staged concepts. These concepts involve, at different time 
points in age, the closure of the bladder, urethral closure, the closure of the abdominal wall 
and later epispadias repair. The surgeon may also perform pelvic osteotomies during the 
primary closure to deepen the flattened pelvis and by doing so also release the tension in the 
abdominal wall. There is no consensus on the best time of surgery and whether to perform an 
osteotomy. 
Retrospective data has shown a continence rate of 80% in childhood, but after childhood the 
number of patients who need a bladder augmentation, a bladder neck plasty or self 
catherization increases. The continence rate also decreases after a redo bladder neck plasty to 
around 40%. If the bladder neck resistance is too low, different injectable materials can be 
used to increase the urethral resistance. Other complications associated with bladder 
exstrophy are vesicoureteric reflux, bladder spasm, stone formation and urinary tract 
infections. If bladder reconstruction fails and the reservoir is too small, bladder augmentation 
can be performed with parts of the bowel, preferably the sigmoid or ileum. Bladder 
augmentation however, has its own complications such as infections, increased mucus 
production, metabolic disturbances, perforation, stone formation and, in addition, a higher 
risk of malignancy. There are today no ideal treatment options with a low risk of 
complications.  
(Sponseller, Bisson et al. 1995, Grady, Carr et al. 1999, Baka-Jakubiak 2000, Greenwell, 
Venn et al. 2001, Nelson, Dunn et al. 2005, Thomas, Duffy et al. 2008, Ebert, Reutter et al. 
2009, Gearhart, Rink et al. 2010, Reinfeldt Engberg, Mantel et al. 2016)  
  15 
 
 
Figure 5: 4 week old girl with bladder exstrophy. 
1.8 HYPOSPADIAS 
Hypospadias is a penile congenital malformation where the urethral opening is located 
ectopically on the ventral side of the penis. The urethral opening can be positioned proximal 
to the scrotum or perineum. Hypospadias is also associated with chordee, a ventral curvature 
of the penis, and a dorsally placed foreskin. The chordee is usually found in the more 
proximal hypospadias. In many cases the scrotum is located cranially leading to a penoscrotal 
transposition.  
Hypospadias is a common malformation and has a prevalence of around 1 in 125 boys in 
Sweden and the United States. Several studies show that the prevalence has increased and is 
not due to only better surveillance systems and a shift in diagnostic criteria (Manson and Carr 
2003, Nordenvall, Frisen et al. 2014). 
Many classifications of hypospadias have been proposed, but one of the most widely used 
was described by Barcat and modified by Ducket. This classification is based on the 
placement of the meatus and called anterior hypospadias (distal of the sub-corona), middle 
hypospadias (on the penile shaft) and posterior hypospadias (penoscrotal to perineal position)  
(Horton 1973, Walsh and Campbell 2002). 
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Figure 6: Different types of hypospadias. The meatus is located at an abnormal position. CC-
SA-1.0. 
The objectives of the surgical correction of hypospadias are to give the boy a straight penis 
with acceptable sexual function, to be able to void with a normal flow, and satisfactory 
cosmetic results where the meatus is slit-shaped and placed distally on the glans. 
The history of hypospadias surgery goes back all the way to ancient Greece where partial 
penectomy was performed. Since then, advancements have focused on enhancements in 
function and cosmetics. In the 19th century the most significant advances occurred such as 
urethroplasty, preputial skin flaps, and multilayered closures. Technical advances in the 
1980s and 1990s led to better appearance and function of, particularly, distal hypospadias.  
The success rate for distal hypospadias is over 90% when excluding adult patients and redo 
surgeries. For proximal hypospadias, the situation is different, and several recent studies have 
shown a complication rate as high as 50-70%, which is higher than the historically lower 
complications rate of 15-30%. This may be due both to longer follow-up times and a larger 
number of patients. Even though many of these patients only require one redo surgery, some 
of them must undergo several and complicated surgeries which leads to high morbidity. 
Although most patients are straight forwardly treated, some are complicated with a severe 
lack of tissue, especially in redo surgery. Different tissue substitutes have been used, such as 
buccal mucosa and preputial skin flaps, but these are also associated with high complication 
rates. 
(Duckett 1981, Snodgrass 1994, Barbagli, Sansalone et al. 2012, Fine, Reda et al. 2015, 
Stanasel, Le et al. 2015, Long and Canning 2016) 
1.9 AIM 
The aim of this thesis was to develop a scaffold suitable for tissue engineering with the 
proper characteristics when treating patients with lack of tissue in the lower urinary tract. The 
scaffold should have a high tensile strength, in the same range as the urinary bladder, be 
compliant, biodegradable, and easy to construct and provide cells with a satisfactory 
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environment to proliferate and create new tissue. We sought to study our transplants both in 
vitro and in vivo. We also wanted to explore the possibilities of using stem cells as a cell 
source when engineering a bladder transplant, so as to also be able to provide a solution for 
patients lacking autologous urothelial cells. 
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2 MATERIALS AND METHODS 
2.1 PCL (STUDIES I, III, IV) 
We used PCL (Sigma-Aldrich) with an average molecular weight of 80,000 g/mol which was 
dried in a vacuum and later compressed into cylindrical rods. Under a nitrogen atmosphere 
the rods underwent melt spinning at 180 oC.  The filaments where drawn at 30 oC and 
subsequently knitted using a Lawson Hemphill FAK-sampler, which has a cylinder of an 89 
mm diameter with 380 needles. Air at a pressure of 40 psi (3 bar) and dry and clean 
instruments were used during the knitting process. By knitting the PCL filaments, a higher 
elasticity is achieved. 
The PCL surface had to become more hydrophilic for better attachment to the collagen. For 
this purpose, the PCL surface was preactivated with an alkaline hydrolysis. The PCL mesh 
was put in 2.5 M NaOH for 40 min at 40 oC, rinsed with distilled water, and placed in PVA 
(Merck; 72,000 g/mol) 1% w/v solution for 10 min. Before use, the PCL-knitted mesh was 
sterilized in 70% ethanol for 30 min. 
2.2 PLGA (STUDY II) 
Preparation of the PLGA solution (20% w/v) (poly(D,L-lactide-co-glycolide); a 
lactide:glycolide ratio of 75:25; molecular weight 66,000e107,000 g/mol) was carried out by 
dissolution in a dry chloroform (Sigma)/DMF(Sigma) mixture under magnetic stirring for 3 h 
at 50 oC. Electrospinning was carried out by a feed rate of 1 mL/h and a voltage of 16 kV 
applied to a 21 gauge blunt needle tip of a 1 mL syringe filled with the PLGA solution. By 
applying it onto a PCL winded tube on the collecting mandrel we acquired the “optimized” 
PLGA mat and, by applying it directly on to the collecting mandrel, we acquired the 
“ordinary” PLGA mat. The rotational speed was 200 rpm, the distance between the collector 
and the needle was 15 cm, the humidity was 50% and the maintained temperature was 24 oC. 
The electrospun mats were vacuum dried for 24 h after being separated from the collector and 
the winded tube. By spinning the PLGA we tried to mimic the extracellular matrix. 
2.3 CONTACT ANGLE MEASUREMENTS (STUDY I) 
A Video-Based Optical Contact Angle Meter (Data-Physics OCA 15EC) was used to 
investigate the hydrophilicity of the alkaline-hydrolyzed and PVA-treated PCL meshes. 
Pieces 4 cm2 were attached on a microscope slide with tape. 6 µL of drop was measured 
automatically while the stage with the slide moved up to put the droplet on top of the sample 
surface. Before the measurement, the drop was left to reach equilibrium and using the SCA 
10 software the contact angles of both sides of the drop were calculated. 
2.4  PREPARATION OF THE SCAFFOLD (STUDIES I-IV) 
Rat-tail collagen type I solution was used (2.06 mg/mL protein in 0.6% acetic acid; First Link 
Ltd.) by mixing 4.8 mL of collagen type I with 0.6 mL of 10X Eagle’s Minimum Essential 
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Medium (Invitrogen, Sweden), afterwards neutralized with 2.5 M NaOH and finally 0.6 mL 
of Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Sweden) was added to the 
mixture. A rectangular or ring-shaped mold was used where one third of the solution was 
poured into the mold and incubated at 37 oC for 10 min to form a semi-rigid gel. The 
sterilized PCL mesh or PLGA mat were put on top of the collagen and the rest of the collagen 
solution was cast upon the polymers. After this, the scaffold was once again put into the 
incubator for the completion of the gel formation. 
2.5  PLASTIC COMPRESSION (STUDIES I-IV) 
Plastic compression was performed on the gel-polymer constructs. The gels were transferred 
to blotting elements consisting of, on the bottom, three sterile gauze pads, on top of these a 
400 µm thick stainless steel mesh with mesh sizes of 200 µm, and above that a sterile nylon 
mesh with a mesh size of 40 µm. The gel-polymer construct was covered with another piece 
of nylon mesh, steel mesh, and on top a loading plate. The load was approximately 120 g and 
was left at room temperature for 5 minutes. With the help of the loading plate water was 
pushed down into the gauze pads and reduced the thickness of the construct from 1 cm to 
under 0.5 mm, thus finalizing the scaffold. 
Figure 7: Preparation of the scaffold. A slab of collagen is poured into the mold and 
incubated for 10 min (1). The PCL mesh or PLGA mat is put on top (2) and collagen is 
poured on top (3) and incubated for another 20 min. Minced tissue is placed on top of the 
scaffold (4) and plastic compression is performed finishing the transplant (5). Adapted from 
Scientific paper I with permission. 
2.6 MINCED TISSUE (STUDIES I, II, IV) 
When preparing the minced tissue from the bladder, the bladder was washed and rinsed in 
DMEM and the mucosa was removed mechanically with scissors. A piece 10x10 mm was cut 
out using a mincing device to produce particles measuring approximately 0.3x0.8 mm. When 
skin was used, everything apart from the epidermis and upper part of dermis was removed 
and the mincing was performed in the same manner.  
For seeding the hybrid scaffold, the minced particles were placed on the gel-polymer 
construct before plastic compression. We opted for a 1 to 6 expansion rate as a proof of 
concept and used the equivalence of 1 cm2 of minced tissue on top of 6 cm2 of scaffold. We 
believe, however, that a higher expansion rate would be possible. 
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2.7  CULTURING AND CHARACTERIZATION OF MESENCHYMAL STEM 
CELLS (STUDY III) 
Bone marrow was harvested and diluted with phosphate-buffered saline (PBS) to a 
concentration of 1x107cells/mL. By density gradient centrifugation on Percoll (Amersham, 
Biosciences, Uppsala, Sweden) mononuclear cells were collected and suspended in DMEM-
low glucose (Invitrogen) with 10% fetal bovine serum (FBS, Sigma) and 1/100 antibiotic 
antimycotic solution (Invitrogen). The collected cells were plated at a density of 1.6x105 
cell/cm2 and cultured at 37 oC in humidified air containing 5% carbon dioxide. The medium 
was changed every 3-4 days and passaged at 70% confluence to a density of 4x103 in culture 
flasks. For our experiments we used cells at passage 3-5. Differentiation to adipogenic, 
chondrogenic and osteogenic cells was established and we also tested for surface expression 
of CD14, CD29, CD31, CD34, CD45, CD73, CD80, CD90, CD105, CD166 and HLA class I 
and class II as previously described (Le Blanc, Tammik et al. 2003). 
2.8 HARVESTING AND CULTURING UROTHELIUM (STUDY III) 
Urothelial cells were harvested by bladder washing with a method developed by our group 
(Fossum, Gustafson et al. 2003). In short, the bladder is accessed by a catheter through the 
urethra and is washed with sterile saline a couple of times using a syringe. The procedure is 
repeated until approximately a total amount of 300 mL has been collected. The saline 
containing the cells is then centrifuged at 500 g and the cell pellet resuspended in DMEM 
(Invitrogen).  
The urothelial cells, as well as in vitro cultured transplants containing minced tissue were 
cultured in epithelial cell medium, containing DMEM and Ham’s F12 (Gibco) in a four to 
one mixture. Other ingredients included were: 10 % fetal bovine serum (Gibco), insulin (5 
µg/mL), hydrocortisone (0.4 µg/mL), adenine (21 µg/mL; Sigma), cholera toxin (10-10 
mol/L), triiodothyronine (2 · 10-9 mol/L), transferrin (5 µg/mL), epidermal growth factor (10 
ng/mL), and antibiotics (50U/mL penicillin and 50 µg/mL streptomycin). Cells were 
maintained at regular incubator settings of 5% carbon dioxide and humidified air at 37 oC.  
When culturing urothelial cells from bladder washings, epidermal growth factor was added 
after 24 h of culture. The cells media were changed three times a week. After two to three 
weeks the cell colonies were passaged to a 25 cm2 flask (passage 1), but we only used 
urothelial cells from passage 2 and onwards in our experiments. 
2.9 INDUCTION OF MESENCHYMAL STEM CELLS TO UROTHELIAL CELLS 
(STUDY III) 
Mesenchymal stem cells from the third passage were used. By using conditioned medium in 
two different ways, mesenchymal stem cells were induced into urothelial cells. The exposure 
to conditioned medium was 14 days with both methods. 
In the first method, mesenchymal stem cells were cultured with conditioned medium gathered 
from urothelial cells. When the urothelial cells where at 70-80% of confluence their medium 
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was collected and removed from any cells through centrifugation and filtered through a mesh 
of 0.2 µm pore size. Consequently, DMEM (Invitrogen) with 10% FBS (Sigma) was added to 
the gathered medium in a four to one ratio. As controls, mesenchymal stem cells where used 
cultured with fresh filtered medium. 
In the second method, mesenchymal stem cells (~3000 cell/cm2) were co-cultured indirectly 
with urothelial cells (~7000 cell/cm2) separated by a barrier membrane of 0.4 µm in pore size 
(24 mm dish, Transwell, Corning 3412). As controls, mesenchymal stem cells cultured in the 
same manner but with allogenic mesenchymal stem cells were used. 
2.10 UROTHELIAL GENE AND PROTEIN EXPRESSION (STUDY III) 
By using RT-PCR, specific gene transcripts can be measured. A specific RNA is changed to 
its DNA complement by reverse transcriptase and, subsequently, the new cDNA is 
exponentially amplified several orders of magnitude before detection. After 14 days of 
induction the differentiation of mesenchymal stem cells into urothelial cells was determined 
by measuring specific gene transcripts by RT-PCR. Using the RNAeasy mini kit (Qiagen) 
RNA was isolated from the cells. We synthesized cDNA by using the cDNA synthesis kit 
(Thermo Scientific) and analyzed transcripts by using the three different PCR conditions; 
94oC for 30 s, 55 oC for 30 s and 72 oC for 30 s during 35 cycles. A 10 min extension step 
was conducted for all our PCR experiments. Using a 1.5% agarose gel the reaction products 
were analyzed by electrophoresis. For internal control, human glyceraldehyde-3-phosphate 
dehydrogenase was used.  
Western blot is a method to detect a specific protein by attaching antibodies and identify the 
protein by gel electrophoresis. Protein expression for differentiation to urothelial cells was 
assessed after 14 days by Western blot. Mesenchymal stem cell lysates were used for western 
blot for urothelial lineage-specific gene expression. Cells were washed with PBS, and 
homogenized in tissue protein extraction reagent with halt protease inhibitor cocktail 
(Thermo Scientific) and thus lysates were obtained. Using SDS-PAGE (15%, Bio-Rad) the 
same amount of protein was separated and moved to a polyvinylidene difluoride membrane 
(GE Healthcare). Unspecific binding was blocked with 5% non-fat dry milk and the 
membrane was incubated with primary antibodies overnight at 4 oC. Thereafter, blots were 
stained with anti-mouse IgG conjugated to horseradish peroxidase (1:2000, Dako) and 
assessed with an enhanced chemiluminescence system (GE Healthcare). 
2.11  HISTOLOGY AND IMMUNOHISTOCHEMISTRY (STUDIES I-IV) 
For morphological studies, either routine staining or specific protein staining is used to 
characterize the cells. Antibodies attach to a specific protein, which can be stained and 
observed.  
All samples containing our scaffold were fixed in formaldehyde solution and dehydrated 
before being embedded in paraffin and cut into 4 µm thick sections. The slides were 
rehydrated and stained with Hematoxylin and Eosin for routine histology. 
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Protein markers were also investigated in our studies. We used the Vectastain elite ABC kit 
(Vector) for immunohistochemistry of our slides. Inactivation of endogenous peroxidase was 
performed with 0.3% hydrogen peroxidase for 15 min. The slides were washed with PBS,  
the primary antibody was added, and the slides were incubated at 4 oC in a humidified 
chamber overnight. After washing with PBS, the samples were incubated with diluted 
secondary antibody for 30 min at 37 oC, washed again, and incubated with Vectastain elite 
ABC reagent for 30 min. Lastly, peroxidase substrate solution was added to the slides and 
incubated until a sufficient stain intensity developed, before being counterstained with 
hematoxylin. 
We used several antibodies to assess the expression of proteins in the cells for the evaluation 
of cell type and proliferation activity. MNF-116 and C11 react with many cytokeratins that 
are found in the intracytoplasmic cytoskeleton of epithelial tissue. MNF-116 reacts to 
cytokeratin 5, 6, 8, 17 and 19, and CK11 reacts to cytokeratin 4, 5, 6, 8, 10, 13 and 18. UpIIIa 
is more specific to urothelial cells and is expressed in the superficial umbrella cells of 
urothelial cells. CK-18 is present in the urogenital tract, but also in other locations such as the 
respiratory and digestive epithelium. 
2.12  TENSILE STRENGTH (STUDIES I,II AND IV) 
We used the Instron 5944 tensile tester with a load of a 50-N load-cell with a crosshead speed 
of 10 mm/min and a gauge length of 40 mm under wet conditions in studies I and II. All 
samples were prepared by incubating in PBS for 24 h at 37 oC. Five measurements were 
performed at each time point. 
In study IV a Shimadzu Autograph ASG-X tensile machine with a 10-N load cell was used. 
Specific fixture was used to clamp the sample and to remove the sample slipping. The gauge 
length of the implant samples was 10-12 mm with a width of 10 mm. With these settings, the 
maximal measurable tensile strength was approximately 2.4 MPa, which is in the same 
magnitude as the normal bladder. (Martins, Filho et al. 2011) Five measurements were 
performed at each time point. 
2.13 ELECTRON MICROSCOPY (STUDY I AND II) 
All the samples were also evaluated by scanning electron microscopy (SEM). After fixation 
in formalin for 1 h, the specimens were washed with distilled water and then passed through a 
graded ethanol series to remove the water. Afterwards, the specimens were put for 15 min in 
hexamethyldisilazane (Sigma-Aldrich), air dried, mounted on stubs and coated with gold 
before examination in a SEM (Zeiss 1550). 
2.14  IN VIVO EXPERIMENT (STUDY IV) 
Male rats (Sprague Dawley) were put in general anesthesia in a box with sevoflurane until 
asleep and then placed on the operating table and kept anesthetized with sevoflurane using a 
mask during the whole procedure.  
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The back of the rat skin was waxed with Veet Easy Wax Removal Strips (Reckitt Benckiser, 
Slough England) and sterilized with Sterillium (Hartmann, Heidenheim, Germany). A 1 cm2 
full skin biopsy was taken from the rat and the lower dermis and the subcutaneous parts were 
removed with scissors leaving only the upper dermis and epidermis (approximately 0.8 mm 
thick). A mincing device was used to cut the upper dermis and epidermis into smaller pieces 
horizontally and vertically to approximately 0.3x0.3 mm pieces. The minced tissue was 
prepared at the same time as the scaffold. Minced skin tissue was distributed on top of the 
scaffold in a 1:6 expansion rate and controls were made without any tissue. Plastic 
compression was performed and scaffolds with or without minced skin were sutured 
subcutaneously on the left or right side of the back of the rat with three single stitches using 
Ethilon 4-0 (Ethicon, Somerville, NJ). For each experiment, one control without minced 
tissue was sutured on the contralateral side of the back of the rat. The distribution between 
right and left side was randomly chosen between tissue-loaded scaffold and control. The 
wounds were closed with Ethilon 4-0 (Ethicon, Somerville, NJ) running sutures. A bandage 
was placed on the wound and the rats were observed until awake. All rats were kept in cages 
with two to three rats in each. After five days, ten days, and four weeks the rats were 
euthanized and samples were taken out for examination. 
  
 
Figure 8: A: Schematic drawing demonstrating the position of the 1x1 cm biopsy on the back 
of the rat skin after depilation. B: Same rat after subcutaneous implantation of scaffolds with 
or without minced skin (squares with interrupted lines) and central wound sutured with 
continuous sutures. Cartoon drawn by Magdalena Fossum. 
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2.15 ETHICS 
For ethical reasons, we try as far as possible to conduct studies in vitro to lower the amount of 
in vivo trials. However, before the developed method can be conducted in a human trial 
animal studies must be performed. By optimizing the in vitro trials, fewer animals will be 
needed, and by also refining the method when performing animal studies, we will have a 
more reliable treatment going into human trials. If possible, we always use smaller animals 
before large animal models if the same information can be gathered. We also try to keep the 
morbidity and mortality as low as possible in accordance with veterinary supervision. Before 
the start of our animal experiment ethics permission was approved by the Swedish Board of 
Agriculture. 
The regional ethics committee in Stockholm approved harvesting of bone marrow in adults, 
and informed consent was obtained from all donors. The ethics committee of the hospital 
approved cell harvesting of urothelial cells from children during surgery after informed 
consent was given by the parents.  
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3 RESULTS 
3.1 STUDY I 
3.1.1 PCL mesh 
After only alkaline hydrolysis the water contract angle on the PCL mesh declined from 104 
±5.3o to 79 ±6.9o, but was not stable over time. By performing hydrolysis followed by a PVA 
adsorption we achieved a stable result and an even greater hydrophilicity with a contact angle 
of 41 ±11.2o (Figure 8). 
 
Figure 9: Water contact angle measurement, showing how hydrophilic properties increase. 
The angle decreased from approximately 104o (a) to 79o after alkaline hydrolysis (b) and was 
further lowered to 41o after subsequent PVA treatment. Adapted from Scientific paper I with 
permission from the publisher. 
After using the hydrophilic PCL-knitted mesh, we achieved a stable integration with the 
collagen and disintegration did not occur during handling of the construct or during the 
culturing period. In the microscale, we observed a nanofibrous structure with an average 
diameter of 47 ±6 nm, which is comparative to that of native extracellular matrix (Mo, Xu et 
al. 2004). When removing the collagen from the PCL surface we could see collagen threads 
in between the PCL mesh (Figure 9). In contrast when non-treated PCL was used, 
spontaneous delamination of the collagen occurred and no anchoring of collagen could be 
seen within the PCL mesh. 
 
Figure 10: SEM images showing the integration of collagen within the PCL-knitted mesh, 
after the collagen has been removed (a). Higher magnification of residual collagen in between 
PCL fibres (b). Further magnification of collagen fibres resembling extracellular matrix (c). 
Adapted from Scientific paper I with permission from the publisher. 
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3.1.2 Tensile strength 
Tensile strength of our hybrid construct was 17.9 ±2.6 MPa compared with 0.6 ±0.12 MPa 
for the collagen only. Mechanical handling of collagen or plastic compressed collagen was 
not possible due to low stability. When culturing on only plastic compressed collagen without 
a PCL mesh, we observed a dimensional change or rupture of the transplant. 
3.1.3 Cell-seeded PCL-collagen scaffolds 
After four weeks of culturing with minced mucosa, phase-contrast microscopy showed that 
the cells had migrated from the minced tissues and spread on top of our construct. SEM 
images visualized a mostly confluent epithelial sheet after two weeks and fully confluent 
layer after four weeks and multi-layered epithelium after six weeks. Histological staining 
confirmed the results at two, four and six weeks. H&E showed a single layer epithelium after 
two weeks and multi-layered epithelium already after four weeks. Cells were also present 
inside the scaffold after six weeks indicating a remodelling of the collagen. 
Immunohistochemistry showed cells positive for Ki-67, indicating proliferation in all 
samples. Cells were also positive for MNF-116 indicating epithelial origin. 
 
Figure 11: Routine histology of the epithelium on top of the collagen (a-c). After six weeks, 
we found a multi-layered epithelium and also cells inside the collagen (c). Brown nuclei cells 
stained for Ki-67, indicating proliferative cells throughout the experiment (d-f). Adapted from 
Scientific paper I with permission from the publisher. 
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3.2 STUDY II 
3.2.1 Characterization of the PLGA scaffold 
 We compared the optimized PLGA mat with the ordinary through SEM images. The 
optimized mat contained altering sections of denser ordinary parts and parts with broadened 
fiber spacing. The average pore diameter in the ordinary PLGA was calculated to 7.54 µm 
compared with 24.12 µm in the optimized samples. Plastic compression resulted in collagen 
fibers with an average diameter of 43 nm, compared with the PLGA fiber diameter of 705 nm 
on average. The hybrid scaffold resulted in a good integration between the collagen and 
PLGA fibers, and collagen fibers could be seen between the PLGA fibers after plastic 
compression. 
 
Figure 12: Ordinary PLGA scaffold (a, left) and optimized PLGA scaffold (a, right). The 
optimized scaffolds demonstrated a clear difference between two different textures (b), as 
shown in higher magnification of the porous parts (c) and the ordinary parts (d). Adapted 
from Scientific paper II with permission from the publisher. 
3.2.2  Tensile strength 
The tensile strength of the collagen was, as previously noted, 0.6 ±0.12 MPa and increased 
six-fold to an average of 3.57 ±1.1 MPa for the hybrid collagen-PLGA scaffold. The stiffness 
and elasticity also increased from 22.7 MPa and 5% elongation at break for plastic-
compressed collagen to 45.5 MPa and 81% elongation at break for the PLGA-collagen 
construct. 
a b 
c d 
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3.2.3  Cell-seeded PLGA-collagen scaffolds 
The placement of the minced tissue either on top or on top and inside the collagen did not 
affect the outcome. With both methods, we observed a single layer epithelium covering the 
scaffold after two weeks and a multilayer epithelium after four weeks. All cells covering the 
scaffold had the morphological characterization of urothelium. Immunostaining of the cells 
for cytokeratins with MNF-116 confirmed the epithelial origin and showed a typical 
transitional urothelium (figure 13). Staining for Ki-67 indicated cell proliferation in all 
samples during the whole experiment (figure 13). 
 
Figure 13: After four weeks in culture cells were positive for Ki-67, indicating a proliferative 
state (a). Cells were also positive for MNF-116, indicating an epithelial origin (b). Adapted 
from Scientific paper II with permission from the publisher. 
3.3 STUDY III 
3.3.1 Characterization of mesenchymal stem cells 
MSCs were successfully isolated, expanded and cultured. They presented a phenotype with 
typical mesenchymal spindle-shaped morphology. When the MSCs were induced in 
adipogenic conditions, the cells changed morphology and produced intracellular droplets 
positive for oil red O staining. When instead being cultured for three weeks in osteogenic 
medium, they could deposit abundant mineralized matrix positive for alizarin red S staining 
and Von Kossa black staining. The cells demonstrated a typical antigen pattern with flow 
cytometry, fulfilling the criteria for MSCs (Le Blanc, Tammik et al. 2003). For more than 
90% of the cells, antigen expression was positive for CD73, CD90, CD105 and HLA class I 
and positive for less than 5%, i.e. negative, for CD14, CD31, CD34, CD45, CD80 and HLA 
class II. 
3.3.2 Characterization of urothelial cells 
Urothelial cells obtained from bladder washings formed colonies and expanded in a 
monolayer, and had typical urothelium growth characteristics and morphology. We 
confirmed the urothelial phenotype with immunostaining for cytokeratin and uroplakin. 
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3.3.3 Induced mesenchymal stem cells 
The mesenchymal morphology changed after 14 days of induction, from spindle-shaped and 
non-colony-forming into a polygonal epithelium-like shape resembling urothelial cells. The 
results were similar with both methods, either cultured with conditioned medium or when 
mesenchymal stem cells were co-cultured with urothelial cells. None of the mesenchymal 
stem cells had the morphology associated with the previous characterization of adipogenic or 
osteogenic lineages. In our control groups the morphology did not change. 
Immunostaining of induced mesenchymal stem cells was positive for specific urothelial 
markers such as CK-18 and UpIIIa, but was not positive in the controls. We estimated 90% of 
the cells were positive for the markers and were believed to have differentiated into a 
urothelial lineage (Figure 13). 
 
Figure 14: Characterization of induced MSCs with urothelial-specific markers after 14 days. 
The induced cells were positive after induction in CM (C,G) and after co-culture (D, H). UCs 
were used as positive controls (A,E) and non-induced MSCs were used as negative controls 
(B, F). Adapted from Scientific paper III, CC-BY 4.0. 
RT-PCR confirmed the amplification of urothelial lineage gene transcripts of UpIIIa and CK-
18, which were upregulated with both induction methods but not the controls. Western blot 
confirmed upregulated protein expression of UpIIIa and CK-18 was distinctly higher in the 
induced cells compared with the controls. CK-18 expression was higher in mesenchymal 
stem cells induced with conditioned medium, than after induction with co-culture. 
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Figure 15: Investigation with RT-PCR (a) and western blot (b) confirmed differentiation to a 
urothelial lineage, by positive results of gene transcription and protein expression of CK-18 
and UpIIIa. Adapted from Scientific paper III, CC-BY 4.0. 
3.3.4 Induced mesenchymal stem cells on PCL-collagen scaffold 
Routine histology verified an epithelial-like confluent cell layer on top of our scaffold in the 
induced MSC samples. Immunostaining was positive for MNF-116, CK-18 and UpIIIa in the 
induced samples and positive controls but not in our non-induced controls.  
 
Figure 16: A comparison between urothelial cells and induced mesenchymal stem cells after 
14 days. The arrowheads indicate the placement of the PCL and the asterisks indicate the 
collagen. UCs were used as positive controls (A-D) and induced MSCs were positive for 
epithelial marker MNF-116 (F) and urothelial specific markers UpIIIa (G) and CK-18 (H). 
Adapted from Scientific paper III, CC-BY 4.0. 
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3.4 STUDY IV 
3.4.1 In vitro results 
Macroscopically, tissue transplants showed no contraction and no delamination occurred 
between the PCL and collagen. Histological staining with H&E demonstrated that a single 
layer epithelium had been formed after two weeks, multilayered epithelium was formed after 
four weeks, and after six weeks a keratinized stratified squamous epithelium was visible in 
vitro.  
3.4.2 Tensile strength 
The transplants kept a high tensile strength throughout the experiment but lost some of their 
elasticity. The highest possible measured strength was 2.4 MPa and most transplants were 
intact at this point. The tensile strength was reduced from a median of 2.4 MPa at the start of 
the experiment to a median of 2.2 MPa after ten days and with higher variability, but after 
four weeks regained its former strength to 2.4 MPa. The elasticity of the construct decreased 
over time. The elongation or elongation at break was virtually unchanged from a median of 
185% at the start of the experiment to 184% at ten days but with higher variability, and had 
been reduced to 123% after four weeks.  
3.4.3  In vivo results 
 All rats survived the course of the study period, did not demonstrate any complications, and 
appeared unaffected by the implants. A total of 11 rats were operated with 24 transplants 
containing minced tissue and 39 transplants with no tissue. A total of 48 samples from the 
three time points (5, 10, 28 days) were collected for histology and 15 samples were collected 
for tensile strength measurements. Tissue growth could be observed already after five days 
and we could observe cells growing from borders of the minced tissue to cover the collagen 
(Figure 17). Clear multilayer epithelium resembling keratinized stratified squamous 
epithelium could be seen at ten days. None of the controls demonstrated epithelial growth. 
Immunohistochemistry confirmed a skin keratinocyte origin (Figure 18). 
Figure 17: Newly regenerated tissue from the transplanted minced particles. Cells (arrow) 
have proliferated from the edge of the minced tissue (*) and covered parts of the collagen (%) 
and PCL (#) scaffold. Day five after transplantation. (H&E) 
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Integration was evaluated by cell ingrowth, visible capillaries, and the loosening and thinning 
of the collagen. The epithelium grew in local areas on top of the collagen and the transplants 
were better integrated when epithelium was present. The integration of the collagen had 
started at five days and was in most parts integrated after ten days and after four weeks the 
collagen was fully integrated in most areas. PCL fibers could be observed unchanged during 
the whole study period in all samples. 
Inflammatory changes with redness were seen macroscopically in one of the samples (1/ 48) 
and confirmed microscopically with penetration of inflammatory cells within the transplant. 
 
Figure 18: Figure demonstrating neo-epithelialization at different time points after 
transplantation. A: Single layer keratinocytes as seen after five days, B: Keratinized stratified 
squamous epithelium after ten days and, C: stratified squamous epithelium with increase of 
keratinization and development of mature interactions to the sub-epithelial tissue with 
epidermal ridges and dermal papilla (arrow) at four weeks. (C11 and HTX) 
 
Figure 19: Figure demonstrating the interactions between the transplant and surrounding 
native tissue at different time points. A and B: Penetration of cells within the collagen (%) 
and reorganization of the collagen was seen already after five and ten days. Capillaries 
(arrow) within the scaffold were formed after 10 days. C: Collagen was fully integrated after 
4 weeks. PCL (#) was unchanged after 4 weeks. (H&E)  
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4 DISCUSSION 
In these studies, we have tried to go beyond the traditional tissue engineering where one 
expands tissue in vitro before transplantation and instead find a way to use our own bodies as 
incubators for the regeneration of tissue. Our objective was to develop an easily assembled 
off-the-shelf scaffold using U.S. Food and Drug Administration (FDA) approved materials 
that could be used in an ordinary surgical setting to expand tissue. We identified that such a 
scaffold needs to provide a beneficial environment for the cells and have the strength to 
sustain surgical handling and manipulation. However, it also needs to keep its strength over 
time to allow the take of the transplants, and tissue regeneration and maturation into 
functional tissue with characteristics that would fulfill the demands related to the intended 
application. We also have explored the possibility of inducing stem cells into urothelium on 
top of our scaffold to also provide a solution for patients with a total lack of tissue. 
We used collagen type I, which is a part of, and resembles, the body’s own extracellular 
matrix for the most substantial part of our scaffold. Collagen is known to enhance cell 
proliferation, activity and orientation, as well as exhibiting low inflammatory and antigenic 
responses. It also contributes to different cellular interactions by incorporating cell-adhesion 
peptide sequences, thus making it suitable for tissue engineering (Furthmayr and Timpl 1976, 
Silver and Pins 1992, Cen, Liu et al. 2008). The tensile strength became greater (0.6±0.12 
MPa) by performing plastic compression of collagen. It would still not be enough for bladder 
augmentation purposes because of the bladder’s high tensile strength (1.9 ±0.2 MPa) 
(Martins, Filho et al. 2011). Another disadvantage was the constriction which appeared when 
we cultured minced tissue on top of only collagen and made the plastic compressed collagen 
lose its form and dimensional shape. The next step was therefore to incorporate a polymer 
inside of our constructs for additional strength. 
Two different polymers were used, PCL which yielded a tensile strength of 17.9 ±2.6 MPa 
and PLGA with a tensile strength of 3.6 ±1.1 MPa. Both polymers have the strength to 
withstand the tensions a bladder is subjected to until new tissue is formed and can withstand 
the regular forces of bladder filling and emptying.  The measurements in our in vivo 
experiment with a PCL-collagen scaffold demonstrated a tensile strength up to 2.4 MPa, 
which is within the normal magnitude for healthy human bladders (Martins, Filho et al. 
2011). The scaffold retained its high tensile strength over a long period and was still elastic 
over the observed four-week period.  These qualities could make the scaffold suitable for 
tissue engineering of organs that need to be elastic, such as the urinary tract and tendons, for 
example the diaphragmatic muscle tendon (Schechtman and Bader 1997). In applications 
where higher elasticity is important, a dynamic or static extension of the scaffold may yield 
an even higher elasticity over time.  
The polymers and the scaffold should preferably slowly degrade over time and be absorbed 
by the body as new cells, vessels and extracellular matrix are formed. The initial weakness of 
the transplant will come from its edges and we would most likely need to drain the bladder 
during the initial healing phase. 
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A common issue with our scaffolds was the attachment between the collagen and the 
different polymers. Our first attempts at combining the PCL and collagen resulted in 
unreliable constructs where the collagen would de-attach. We believed this was due to the 
hydrophobic nature of the PCL surface. After alkaline hydrolysis and treatment with PVA as 
previously described for similar cases (Pattison, Wurster et al. 2005), the PCL-mesh became 
more hydrophilic, which yielded an integrated construct. The same issues arose when trying 
to integrate collagen and PLGA. This time, we thought it depended on the pore size, and by 
increasing the pore size to around 3 times the collagen could integrate into the PLGA-mat. 
Part of the reason for this is the plastic compression which presses the collagen in between 
the PLGA fibers. Larger pore sizes may also lead to easier infiltration and migration of cells 
inside the transplant in an in vivo setting. When working with these materials we also found 
that the risk for collagen to polymer dehiscence decreased with larger sized transplants. 
Our PCL- and PLGA-based scaffolds seeded with minced tissue either on top or inside the 
collagen showed a successful proliferation and migration of urothelial cells. We also 
observed a migration from cells both on top and inside the constructs. The cells reorganized 
on top of both types of scaffolds and after two weeks a proliferative monolayer had been 
formed. A multilayer epithelium was visible already after four weeks and was positive for 
both MNF-116 and Ki-67. This indicates the cells have an epithelial origin and are 
proliferative during the whole experiment. Cell division was mostly located in the lower 
layers of the multilayered epithelium, representating a basal membrane and resembling a 
transitional urothelium.  
Even though the cell culturing properties of our scaffolds are similar, several differences are 
present between the PCL and PLGA scaffolds. The PCL has a higher tensile strength of 17.9 
compared with 3.6 MPa for the PLGA and is easier to handle surgically. The PLGA on the 
other hand has a faster degradability than PCL; six months compared with two years 
(Gunatillake and Adhikari 2003). The PLGA was also possible to produce as a thinner mat, in 
our studies around 200 µm compared with 400 µm for the PCL-mesh, which would introduce 
less amount of synthetic material inside the body. Despite these differences, the results of 
both scaffolds are representative and it shows that neither the PCL nor the PLGA has a clear 
advantage. Even though in vivo studies may later prove a clinical advantage, the use of either 
polymer can be decided for other reasons if the previously stated differences are not highly 
important for the intended application. Other practical reasons for choosing either polymer 
may be the availability and the price. In Studies III and IV we opted for the PCL-collagen 
hybrid scaffold because of easier access to PCL. 
With patients lacking autologous urothelium, such as after cancer treatment, severe trauma or 
mutilating surgery, minced mucosa may not be available for tissue engineering purposes as 
previously described. In these cases, multipotent stem cells may provide a solution. 
Mesenchymal stem cells are multipotent cells which reside in many places of the body. 
Mesenchymal stem cells are suitable for tissue engineering purposes because of their 
advantageous properties, such as high differentiation potential, anti-inflammatory, non-
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immunogenic properties and low oncogenic risk (Pittenger, Mackay et al. 1999, 
Bartholomew, Sturgeon et al. 2002, Hare, Traverse et al. 2009, Prockop, Brenner et al. 2010). 
Other advantages are the ease of isolation of mesenchymal stem cells, which are already used 
in clinical trials, and the possibility to differentiate mesenchymal stem cells into ectodermal 
and endodermal lineages as well as a mesodermal lineage (Petersen, Bowen et al. 1999, 
Sanchez-Ramos, Song et al. 2000, Oswald, Boxberger et al. 2004, Le Blanc, Frassoni et al. 
2008, Hare, Traverse et al. 2009, Connick, Kolappan et al. 2012). 
Other groups have been able to use stem cells from adipose tissue and bone marrow and 
differentiate these into urothelial-like cells by exposure to a certain microenvironment (Tian, 
Bharadwaj et al. 2010, Ning, Li et al. 2011, Shi, Fu et al. 2012). We showed the possibility to 
differentiate adult mesenchymal stem cells into urothelial-like cells, using urothelium 
acquired with a minimally invasive method. Through bladder washings, urothelial cells were 
collected and the patient only had to undergo catheterization. This gives us a secure and easy 
way to collect urothelial cells for our differentiation purposes, and should therefore strongly 
facilitate the recruitment of donors. 
The mesenchymal stem cells could be differentiated to urothelium through both conditioned 
medium and co-culturing. These results suggest that a substance is produced by the 
proliferating urothelial cells which leads the stem cells into a urothelial lineage. In theory, 
mesenchymal stem cells in the blood stream could therefore have a role in bladder wound 
healing. Here an autocrine and paracrine cell signaling could take place through the cell 
medium, but we did not investigate a juxtacrine model. Even though juxtacrine signaling may 
yield better results, but in our clinical scenario, autologous urothelial cells will not be 
available and we will not be able to use juxtacrine signaling for differentiation. 
 To evaluate our differentiation method for future clinical implementation we examined the 
differentiation of mesenchymal stem cells on top of a PCL-collagen based scaffold suitable 
for the urinary system. We could show a good attachment and proliferation of cells, as well as 
differentiation of mesenchymal stem cells on top of the hybrid scaffold after forming a 
confluent epithelial cell layer. In a clinical setting, urothelial cells from different donors 
would be frozen and stored to be used two weeks before the intended surgery with our 
transplant. 
At this point we did not intend to incorporate the scaffold to the urinary bladder of a small 
animal model, in our case the rat, due to its small bladder size. To evaluate the integration and 
regeneration of a transplant it is crucial to evaluate a critical sized defect that cannot be 
healed in the body by contraction or ingrowth solely from the borders. A small-sized bladder 
defect would therefore not have given us results representative of human bladders. Therefore, 
we preferred to evaluate basic characteristics of the scaffolds such as: integration, tolerance 
and tensile strength in a small animal model as a first step. In addition, as we would only be 
able to harvest a small amount of bladder tissue for autologous transplantation to the same 
animal (only one tissue-loaded transplant per animal) that would also lead to a higher number 
of animals needed for the study. 
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The rational for using a small animal model was to evaluate the composite biomaterial 
including minced autologous epithelium after in vivo transplantation. During this step, where 
we only wanted to study tissue integration and epithelial tissue expansion, we could use a 
rodent model and decrease the number of large animals needed within the project.  
Before our in vivo experiment (Study IV), we evaluated the scaffold with minced skin in vitro 
to make sure our scaffold was also feasible with skin. Analogous with bladder mucosa, we 
found that a single layer epithelium had formed after two weeks, a multilayer epithelium after 
four weeks and a keratinized stratified squamous epithelium was visible after six weeks in 
vitro.  
The results of our in vivo studies showed that our scaffolds were totally integrated with 
surrounding tissue after four weeks, and were already integrated after ten days, as 
demonstrated by vascularization within the construct. We observed epithelial cells on top of 
the scaffold after five days, which demonstrates reorganization of minced tissue by migration 
and early proliferation of cells from minced tissues to the surface of the scaffold.  A mature 
keratinized stratified squamous epithelium was present after four weeks. Our three-
dimensional scaffold kept its tensile strength during the whole experiment and kept most of 
its elasticity despite the static conditions prevailing in the present experimental model. 
We can now describe basic data that help us estimate changes in scaffold behavior in vivo 
over time. Integration of the scaffold takes approximately four weeks; this data is helpful for 
future in vivo studies where we aim at integrating the scaffold into the urinary system in a 
large animal model. We also confirmed that it would be possible to expand epithelial cells in 
vivo by placement on top of the scaffold prior to transplantation. We also observed a higher 
integration rate where the epithelial cells were located. These findings allow us to estimate 
how much time the scaffold needs to integrate inside the body, with or without minced tissue 
during the healing process. 
 In our pilot study, we used a rodent full-thickness skin wound model for the experiments, by 
these means the scaffolds were placed in the bottom of skin wounds that were held moist and 
covered with dressings as described in previous studies (Hackl, Bergmann et al. 2012). 
Unfortunately, the rats could escape their dressings and damage the transplants. We also 
noticed a pronounced contraction of the rat skin that would disturb further evaluation of the 
neo-regeneration around the transplant itself. Despite applying methods described in previous 
studies we could not prevent the constriction of the skin and the transplants were affected 
(Bae, Bae et al. 2012). We then decided to evaluate the transplant subcutaneously and not in a 
full skin wound model. In this model, the rats could not influence the transplant by scratching 
or biting and therefore the scaffold properties could be better evaluated. In addition, the 
subcutaneous implantation did not seem to disturb the rats as did the full-thickness wounds, 
which included a postoperative dressing. The downside of this modified model was that 
epithelial cells could not expand and cover all the scaffold surface, most likely due to the lack 
of discrepancy between air and tissue to guide proliferation. Therefore, as expected, the 
epithelial cells grew in clusters or in smaller areas on top of the collagen. 
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When deciding on our experimental setup we concluded that a skin wound model would be 
the most ethical way to proceed. Even though our main goal was to find a scaffold suitable 
for bladder augmentation a skin model required fewer rats and less morbidity for the animals. 
Previous studies have shown that a bladder rat model is not best suited for assessing how well 
a transplant will behave in large animal or human models (Sloff, Simaioforidis et al. 2014). 
This might be caused by the difference in bladder size and size of defect; a smaller bladder 
and wound may heal better because of easier cell migration and tissue contraction instead of 
relying on neo-regeneration. Therefore, in future studies we will allow for a critical size 
defect in our next experimental model that is comparable with human bladders.  
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5 CONCLUSIONS 
5.1 STUDIES I AND II 
We were able to construct a suitable scaffold for minced mucosa which can bypass the 
laborious, expensive and time consuming process of in vitro culture for tissue engineering, 
and instead have the possibility to expand tissue inside our own bodies. Our new hybrid 
scaffold consists of collagen as an outer part and is strengthened in the middle with a PCL 
mesh or a PLGA mat. The mechanical properties improved significantly when introducing 
PCL or PLGA into the scaffold, and the tensile strength was at the same magnitude or more 
than the bladder. Collagen and both polymers integrated well after specific optimization. In 
our in vitro studies, we saw the scaffold provide the minced tissue with an advantageous 
environment for cell proliferation and migration. With SEM and histology, we could observe 
a single layer epithelium covering the collagen after two weeks and a multilayered epithelium 
after four weeks. With these new scaffolds, we envision a clinical scenario where the surgeon 
can perform a bladder augmentation during one single surgical procedure with the patient’s 
own mucosa, and the time between tissue collection and a finished transplant would be 30-40 
min. Because the tissue is autologous there is no risk of rejection. This method could be 
performed in smaller hospitals lacking advanced laboratories and could make tissue 
engineering available for more patients. 
5.2  STUDY III 
For patients with a total lack of tissue, conventional tissue engineering or expanding tissue 
with minced pieces is not possible. In these cases, we can use mesenchymal stem cells 
collected from the bone marrow as a cell source for tissue engineering. We could differentiate 
mesenchymal stem cells into urothelial-like cells after two weeks in a microenvironment 
consisting of the growth medium of proliferating urothelial cells. Mesenchymal stem cells 
were also able to differentiate on top of a collagen-PCL based scaffold suitable for tissue 
engineering of the urogenital tract. Further studies are needed to explore the molecular 
mechanisms and evaluate the differentiated stem cells in vivo before a clinical trial could take 
place. 
5.3 STUDY IV 
By adding minced tissue to a collagen gel including a PCL-knitted fabric, cell expansion and 
re-organization of the epithelium could take place without the need for conventional in vitro 
cell culturing. Transplant properties seemed favorable over time in vivo. The method was 
simple and could be used as a one-stage procedure in an ordinary surgical unit for tissue 
expansion and could be implemented for bladder augmentation. The next step would be to 
evaluate the transplant with an autologous bladder epithelium in a large animal model. 
  
  39 
 
6  ACKNOWLEDGEMENTS 
 
Thanks to my supervisors Magdalena and Agneta for giving me this research opportunity, as 
well as all the help and support during these years. 
Thanks to my colleagues, lab partners and collaborators for all the help and for teaching me 
everything I know. 
Thanks to the institutions and foundations who financed this work. 
Thanks to my family for always being there for me and supporting my work. 
Thanks to my friends for all the fun times during this stressful period. 
Thanks to everyone at Stockholm BJJ Center for getting my mind of my work with good rolls 
and tough training. 
Thanks to my fiancé Marika for all the love and for tolerating all my projects. 
Thanks to Oscari for just eating some of my papers during these last months. 
 
  41 
7 REFERENCES 
Bae, S. H., Y. C. Bae, S. B. Nam and S. J. Choi (2012). "A skin fixation method for 
decreasing the influence of wound contraction on wound healing in a rat model." Arch Plast 
Surg 39(5): 457-462. 
Baka-Jakubiak, M. (2000). "Combined bladder neck, urethral and penile reconstruction in 
boys with the exstrophy-epispadias complex." BJU Int 86(4): 513-518. 
Barbagli, G., S. Sansalone, R. Djinovic and M. Lazzeri (2012). "Surgical Repair of Late 
Complications in Patients Having Undergone Primary Hypospadias Repair during Childhood: 
A New Perspective." Adv Urol 2012: 705212. 
Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. 
Devine, D. Ucker, R. Deans, A. Moseley and R. Hoffman (2002). "Mesenchymal stem cells 
suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo." Exp 
Hematol 30(1): 42-48. 
Bauge, C. and K. Boumediene (2015). "Use of Adult Stem Cells for Cartilage Tissue 
Engineering: Current Status and Future Developments." Stem Cells Int 2015: 438026. 
Bernardo, M. E., N. Zaffaroni, F. Novara, A. M. Cometa, M. A. Avanzini, A. Moretta, D. 
Montagna, R. Maccario, R. Villa, M. G. Daidone, O. Zuffardi and F. Locatelli (2007). 
"Human bone marrow derived mesenchymal stem cells do not undergo transformation after 
long-term in vitro culture and do not exhibit telomere maintenance mechanisms." Cancer Res 
67(19): 9142-9149. 
Bowland, P., E. Ingham, L. Jennings and J. Fisher (2015). "Review of the biomechanics and 
biotribology of osteochondral grafts used for surgical interventions in the knee." Proc Inst 
Mech Eng H 229(12): 879-888. 
Brown, R. A., M. Wiseman, C. B. Chuo, U. Cheema and S. N. Nazhat (2005). "Ultrarapid 
Engineering of Biomimetic Materials and Tissues: Fabrication of Nano- and Microstructures 
by Plastic Compression." Adv. Funct. Mater. Advanced Functional Materials 15(11): 1762-
1770. 
Cen, L., W. Liu, L. Cui, W. Zhang and Y. Cao (2008). "Collagen tissue engineering: 
development of novel biomaterials and applications." Pediatr Res 63(5): 492-496. 
Chester, D. L., D. S. Balderson and R. P. Papini (2004). "A review of keratinocyte delivery to 
the wound bed." J Burn Care Rehabil 25(3): 266-275. 
Connick, P., M. Kolappan, C. Crawley, D. J. Webber, R. Patani, A. W. Michell, M. Q. Du, S. 
L. Luan, D. R. Altmann, A. J. Thompson, A. Compston, M. A. Scott, D. H. Miller and S. 
Chandran (2012). "Autologous mesenchymal stem cells for the treatment of secondary 
progressive multiple sclerosis: an open-label phase 2a proof-of-concept study." Lancet 
Neurol 11(2): 150-156. 
Duckett, J. W. (1981). "MAGPI (meatoplasty and glanuloplasty): a procedure for subcoronal 
hypospadias." Urol Clin North Am 8(3): 513-519. 
Ebert, A. K., H. Reutter, M. Ludwig and W. H. Rosch (2009). "The exstrophy-epispadias 
complex." Orphanet J Rare Dis 4: 23. 
Engelhardt, E. M., E. Stegberg, R. A. Brown, J. A. Hubbell, F. M. Wurm, M. Adam and P. 
Frey (2010). "Compressed collagen gel: a novel scaffold for human bladder cells." J Tissue 
Eng Regen Med 4(2): 123-130. 
 42 
Fine, R., E. F. Reda, P. Zelkovic, J. Gitlin, J. Freyle, I. Franco and L. S. Palmer (2015). 
"Tunneled buccal mucosa tube grafts for repair of proximal hypospadias." J Urol 193(5 
Suppl): 1813-1817. 
Fossum, M., C. J. Gustafson, A. Nordenskjold and G. Kratz (2003). "Isolation and in vitro 
cultivation of human urothelial cells from bladder washings of adult patients and children." 
Scand J Plast Reconstr Surg Hand Surg 37(1): 41-45. 
Fossum, M., J. Svensson, G. Kratz and A. Nordenskjold (2007). "Autologous in vitro 
cultured urothelium in hypospadias repair." J Pediatr Urol 3(1): 10-18. 
Fowler, C. J., D. Griffiths and W. C. de Groat (2008). "The neural control of micturition." 
Nat Rev Neurosci 9(6): 453-466. 
Furthmayr, H. and R. Timpl (1976). "Immunochemistry of collagens and procollagens." Int 
Rev Connect Tissue Res 7: 61-99. 
Gearhart, J. P., R. C. Rink and P. D. E. Mouriquand. (2010). "Pediatric urology." from 
http://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-B9781416032045X00011. 
Grady, R. W., M. C. Carr and M. E. Mitchell (1999). "Complete primary closure of bladder 
exstrophy. Epispadias and bladder exstrophy repair." Urol Clin North Am 26(1): 95-109, viii. 
Greenwell, T. J., S. N. Venn and A. R. Mundy (2001). "Augmentation cystoplasty." BJU Int 
88(6): 511-525. 
Gunatillake, P. A. and R. Adhikari (2003). "Biodegradable synthetic polymers for tissue 
engineering." Eur Cell Mater 5: 1-16; discussion 16. 
Hackl, F., J. Bergmann, S. R. Granter, T. Koyama, E. Kiwanuka, B. Zuhaili, B. Pomahac, E. 
J. Caterson, J. P. Junker and E. Eriksson (2012). "Epidermal regeneration by micrograft 
transplantation with immediate 100-fold expansion." Plast Reconstr Surg 129(3): 443e-452e. 
Hare, J. M., J. H. Traverse, T. D. Henry, N. Dib, R. K. Strumpf, S. P. Schulman, G. 
Gerstenblith, A. N. DeMaria, A. E. Denktas, R. S. Gammon, J. B. Hermiller, Jr., M. A. 
Reisman, G. L. Schaer and W. Sherman (2009). "A randomized, double-blind, placebo-
controlled, dose-escalation study of intravenous adult human mesenchymal stem cells 
(prochymal) after acute myocardial infarction." J Am Coll Cardiol 54(24): 2277-2286. 
Horch, R. E., J. Kopp, U. Kneser, J. Beier and A. D. Bach (2005). "Tissue engineering of 
cultured skin substitutes." J Cell Mol Med 9(3): 592-608. 
Horton, C. E. (1973). Plastic and reconstructive surgery of the genital area by 76 contributing 
authors. Boston, Little, Brown. 
Joseph, D. B., J. G. Borer, R. E. De Filippo, S. J. Hodges and G. A. McLorie (2014). 
"Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study 
in children and adolescents with spina bifida." J Urol 191(5): 1389-1395. 
Kanitakis, J. (2002). "Anatomy, histology and immunohistochemistry of normal human 
skin." Eur J Dermatol 12(4): 390-399; quiz 400-391. 
Kingsnorth, A. N., P. N. Skandalakis, G. L. Colborn, T. A. Weidman, L. J. Skandalakis and J. 
E. Skandalakis (2000). "Embryology, anatomy, and surgical applications of the preperitoneal 
space." Surg Clin North Am 80(1): 1-24. 
Koc, O. N., S. L. Gerson, B. W. Cooper, S. M. Dyhouse, S. E. Haynesworth, A. I. Caplan and 
H. M. Lazarus (2000). "Rapid hematopoietic recovery after coinfusion of autologous-blood 
  43 
stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer 
patients receiving high-dose chemotherapy." J Clin Oncol 18(2): 307-316. 
Le Blanc, K., F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, 
M. E. Bernardo, M. Remberger, G. Dini, R. M. Egeler, A. Bacigalupo, W. Fibbe, O. Ringden, 
B. Developmental Committee of the European Group for and T. Marrow (2008). 
"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host 
disease: a phase II study." Lancet 371(9624): 1579-1586. 
Le Blanc, K., I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel and O. 
Ringden (2004). "Treatment of severe acute graft-versus-host disease with third party 
haploidentical mesenchymal stem cells." Lancet 363(9419): 1439-1441. 
Le Blanc, K., L. Tammik, B. Sundberg, S. E. Haynesworth and O. Ringden (2003). 
"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic 
responses independently of the major histocompatibility complex." Scand J Immunol 57(1): 
11-20. 
Li, M., M. J. Mondrinos, X. Chen, M. R. Gandhi, F. K. Ko and P. I. Lelkes (2006). "Co-
electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering 
scaffolds." J Biomed Mater Res A 79(4): 963-973. 
Long, C. J. and D. A. Canning (2016). "Proximal hypospadias: we aren't always keeping our 
promises." F1000Research 5. 
Manson, J. M. and M. C. Carr (2003). "Molecular epidemiology of hypospadias: review of 
genetic and environmental risk factors." Birth Defects Res A Clin Mol Teratol 67(10): 825-
836. 
Martins, P. A., A. L. Filho, A. M. Fonseca, A. Santos, L. Santos, T. Mascarenhas, R. M. 
Jorge and A. J. Ferreira (2011). "Uniaxial mechanical behavior of the human female bladder." 
Int Urogynecol J 22(8): 991-995. 
McBane, J. E., S. Sharifpoor, R. S. Labow, M. Ruel, E. J. Suuronen and J. P. Santerre (2012). 
"Tissue engineering a small diameter vessel substitute: engineering constructs with select 
biomaterials and cells." Curr Vasc Pharmacol 10(3): 347-360. 
Meek, C. P. (1958). "Successful microdermagrafting using the Meek-Wall microdermatome." 
Am J Surg 96(4): 557-558. 
Mo, X. M., C. Y. Xu, M. Kotaki and S. Ramakrishna (2004). "Electrospun P(LLA-CL) 
nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell 
proliferation." Biomaterials 25(10): 1883-1890. 
Nelson, C. P., R. L. Dunn and J. T. Wei (2005). "Contemporary epidemiology of bladder 
exstrophy in the United States." J Urol 173(5): 1728-1731. 
Newman, J. and G. N. Antonakopoulos (1989). "The fine structure of the human fetal urinary 
bladder. Development and maturation. A light, transmission and scanning electron 
microscopic study." J Anat 166: 135-150. 
Ning, J., C. Li, H. Li and J. Chang (2011). "Bone marrow mesenchymal stem cells 
differentiate into urothelial cells and the implications for reconstructing urinary bladder 
mucosa." Cytotechnology 63(5): 531-539. 
Nordenvall, A. S., L. Frisen, A. Nordenstrom, P. Lichtenstein and A. Nordenskjold (2014). 
"Population based nationwide study of hypospadias in Sweden, 1973 to 2009: incidence and 
risk factors." J Urol 191(3): 783-789. 
 44 
Oswald, J., S. Boxberger, B. Jorgensen, S. Feldmann, G. Ehninger, M. Bornhauser and C. 
Werner (2004). "Mesenchymal stem cells can be differentiated into endothelial cells in vitro." 
Stem Cells 22(3): 377-384. 
Pattison, M. A., S. Wurster, T. J. Webster and K. M. Haberstroh (2005). "Three-dimensional, 
nano-structured PLGA scaffolds for bladder tissue replacement applications." Biomaterials 
26(15): 2491-2500. 
Petersen, B. E., W. C. Bowen, K. D. Patrene, W. M. Mars, A. K. Sullivan, N. Murase, S. S. 
Boggs, J. S. Greenberger and J. P. Goff (1999). "Bone marrow as a potential source of 
hepatic oval cells." Science 284(5417): 1168-1170. 
Phull, H. S., H. Q. Pan, R. S. Butler, D. E. Hansel and M. S. Damaser (2011). "Vulnerability 
of continence structures to injury by simulated childbirth." Am J Physiol Renal Physiol 
301(3): F641-649. 
Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. 
Moorman, D. W. Simonetti, S. Craig and D. R. Marshak (1999). "Multilineage potential of 
adult human mesenchymal stem cells." Science 284(5411): 143-147. 
Prockop, D. J., M. Brenner, W. E. Fibbe, E. Horwitz, K. Le Blanc, D. G. Phinney, P. J. 
Simmons, L. Sensebe and A. Keating (2010). "Defining the risks of mesenchymal stromal 
cell therapy." Cytotherapy 12(5): 576-578. 
Rasouly, H. M. and W. Lu (2013). "Lower urinary tract development and disease." Wiley 
Interdiscip Rev Syst Biol Med 5(3): 307-342. 
Reinfeldt Engberg, G., J. Lundberg, C. I. Chamorro, A. Nordenskjold and M. Fossum (2013). 
"Transplantation of autologous minced bladder mucosa for a one-step reconstruction of a 
tissue engineered bladder conduit." Biomed Res Int 2013: 212734. 
Reinfeldt Engberg, G., A. Mantel, M. Fossum and A. Nordenskjold (2016). "Maternal and 
fetal risk factors for bladder exstrophy: A nationwide Swedish case-control study." J Pediatr 
Urol 12(5): 304 e301-304 e307. 
Sanchez-Ramos, J., S. Song, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A. Willing, T. B. 
Freeman, S. Saporta, W. Janssen, N. Patel, D. R. Cooper and P. R. Sanberg (2000). "Adult 
bone marrow stromal cells differentiate into neural cells in vitro." Exp Neurol 164(2): 247-
256. 
Schechtman, H. and D. L. Bader (1997). "In vitro fatigue of human tendons." J Biomech 
30(8): 829-835. 
Schultheiss, D., D. A. Bloom, J. Wefer and U. Jonas (2000). "Tissue engineering from Adam 
to the zygote: historical reflections." World J Urol 18(1): 84-90. 
Shafik, A. (1996). "Ureterovesical junction inhibitory reflex and vesicoureteral junction 
excitatory reflex: description of two reflexes and their role in the ureteric antireflux 
mechanism." Urol Res 24(6): 339-343. 
Shi, J. G., W. J. Fu, X. X. Wang, Y. D. Xu, G. Li, B. F. Hong, K. Hu, F. Z. Cui, Y. Wang and 
X. Zhang (2012). "Transdifferentiation of human adipose-derived stem cells into urothelial 
cells: potential for urinary tract tissue engineering." Cell Tissue Res 347(3): 737-746. 
Silver, F. H. and G. Pins (1992). "Cell growth on collagen: a review of tissue engineering 
using scaffolds containing extracellular matrix." J Long Term Eff Med Implants 2(1): 67-80. 
Sloff, M., V. Simaioforidis, R. de Vries, E. Oosterwijk and W. Feitz (2014). "Tissue 
engineering of the bladder--reality or myth? A systematic review." J Urol 192(4): 1035-1042. 
  45 
Snodgrass, W. (1994). "Tubularized, incised plate urethroplasty for distal hypospadias." J 
Urol 151(2): 464-465. 
Sponseller, P. D., L. J. Bisson, J. P. Gearhart, R. D. Jeffs, D. Magid and E. Fishman (1995). 
"The anatomy of the pelvis in the exstrophy complex." J Bone Joint Surg Am 77(2): 177-189. 
Stanasel, I., H. K. Le, A. Bilgutay, D. R. Roth, E. T. Gonzales, Jr., N. Janzen, C. J. Koh, P. 
Gargollo and A. Seth (2015). "Complications following Staged Hypospadias Repair Using 
Transposed Preputial Skin Flaps." J Urol 194(2): 512-516. 
Tanaka, S. T., K. Ishii, R. T. Demarco, J. C. t. Pope, J. W. Brock, 3rd and S. W. Hayward 
(2010). "Endodermal origin of bladder trigone inferred from mesenchymal-epithelial 
interaction." J Urol 183(1): 386-391. 
Thomas, D. F. M., P. G. Duffy and A. M. K. Rickwood. (2008). "Essentials of paediatric 
urology." from http://www.crcnetbase.com/isbn/9780203091456. 
Thomas, J. C., R. T. DeMarco and J. C. t. Pope (2005). "Molecular biology of ureteral bud 
and trigonal development." Curr Urol Rep 6(2): 146-151. 
Tian, H., S. Bharadwaj, Y. Liu, P. X. Ma, A. Atala and Y. Zhang (2010). "Differentiation of 
human bone marrow mesenchymal stem cells into bladder cells: potential for urological 
tissue engineering." Tissue Eng Part A 16(5): 1769-1779. 
Urmacher, C. (1990). "Histology of normal skin." Am J Surg Pathol 14(7): 671-686. 
Walsh, P. C. and M. Campbell (2002). Campbell's urology. Vol. 1. Vol. 1. Philadelphia, Pa.; 
London, Saunders. 
Walters, M. D. and M. M. Karram. (2015). "Urogynecology and Reconstructive Pelvic 
Surgery." from http://public.eblib.com/choice/publicfullrecord.aspx?p=2072427. 
Wein, A. J., L. R. Kavoussi, A. W. Partin, C. Peters, M. F. Campbell and P. C. Walsh. 
(2016). "Campbell-Walsh urology." from 
https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20121035874. 
Viana, R., E. Batourina, H. Huang, G. R. Dressler, A. Kobayashi, R. R. Behringer, E. 
Shapiro, T. Hensle, S. Lambert and C. Mendelsohn (2007). "The development of the bladder 
trigone, the center of the anti-reflux mechanism." Development 134(20): 3763-3769. 
Vize, P. D., A. S. Woolf and J. B. L. Bard (2003). The kidney : from normal development to 
congenital disease. San Diego, Calif., Academic Press. 
von Bahr, L., I. Batsis, G. Moll, M. Hagg, A. Szakos, B. Sundberg, M. Uzunel, O. Ringden 
and K. Le Blanc (2012). "Analysis of tissues following mesenchymal stromal cell therapy in 
humans indicates limited long-term engraftment and no ectopic tissue formation." Stem Cells 
30(7): 1575-1578. 
Woo, L. L., A. Hijaz, M. Kuang, M. S. Penn, M. S. Damaser and R. R. Rackley (2007). 
"Over expression of stem cell homing cytokines in urogenital organs following vaginal 
distention." J Urol 177(4): 1568-1572. 
Woodruff, M. A. and D. W. Hutmacher. (2010). "The return of a forgotten polymer : 
Polycaprolactone in the 21st century." from http://eprints.qut.edu.au/32270/. 
Yucel, S. and L. S. Baskin (2004). "An anatomical description of the male and female 
urethral sphincter complex." J Urol 171(5): 1890-1897. 
 
